Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.99
- Piotroski Score 3.00
- Grade Neutral
- Symbol (RAPT)
- Company RAPT Therapeutics, Inc.
- Price $1.95
- Changes Percentage (-2.03%)
- Change -$0.04
- Day Low $1.90
- Day High $1.98
- Year High $27.35
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $48.00
- High Stock Price Target $55.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.08
- Trailing P/E Ratio -1.25
- Forward P/E Ratio -1.25
- P/E Growth -1.25
- Net Income $-116,798,000
Income Statement
Quarterly
Annual
Latest News of RAPT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Submit a question for Eric Koreen's Raptors mailbag
At the Toronto Raptors' practice facility, "September" by Earth, Wind, and Fire is a favorite song, loved by coach Nick Nurse. It sets the mood for media sessions, reflecting the team's championship s...
By The New York Times | 1 week ago -
Racked by Pain and Enraptured by a Right-Wing Miracle Cure
Michael Chesebro found solace in Patriot Party News, where he connected with like-minded individuals and immersed himself in conspiracy theories like the "medbed." The platform provided a community an...
By The New York Times | 1 month ago -
Raptors Waive Vezenkov And Freeman-Liberty: What's Next?
The Toronto Raptors have waived guards Javon Freeman-Liberty and Sasha Vezenkov, opening up roster spots and financial flexibility. This move allows them to consider adding new players or re-signing o...
By Forbes | 1 month ago
